Our Bureau

Hyderabad, July 7

AUROBINDO Pharma Ltd has announced that it was granted the certificate of suitability of monographs of the European Pharmacopoeia by the European Directorate for the Quality of Medicines for its active pharmaceutical ingredient Metformin Hydrochloride.

According to a press release here, the company would have the license to sell the above API in entire Europe without any restrictions of places.

(This article was published in the Business Line print edition dated July 8, 2005)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.